Skip to main content
Atrás
Watch Compare

Drugs Made In America Acquisition Corp.

Calidad de datos: 83%
También listada como DMAAU Nasdaq DMAAR Nasdaq
DMAA
Nasdaq Financial Services Holding & Investment Offices
$10.52
$0.00 (0.00%)
Cap. Mercado: 352.43 M
Precio
$10.52
Cap. Mercado
352.43 M
Rango del Día
$10.52 — $10.52
Rango de 52 Semanas
$10.03 — $10.52
Volumen
17
Apertura $10.51
Promedio 50D / 200D
$10.46
0.50% above
Promedio 50D / 200D
$10.34
1.72% above

Quick Summary

Puntos Clave

Negative free cash flow of -586,272.0
P/E of 64.69 — premium valuation

Crecimiento

Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Calidad

Return on Equity
N/A
ROICN/A
Net MarginN/A
Op. MarginN/A

Seguridad

Debt / Equity
N/A
Current Ratio0.06
Interest CoverageN/A

Valoración

PE (TTM)
64.69
Above sector avg (11.15)
P/B RatioN/A
EV/EBITDAN/A
Dividend YieldN/A

Historial de Precios

Tendencias Financieras

Comparación con Pares

vs mediana del sector Financial Services (2150 pares)
Métrica Acción Mediana del Sector
P/E 64.7 11.2
P/B — 1.2
ROE % — 9.2
Net Margin % — 9.4
Rev Growth 5Y % — 5.8
D/E — 0.5

ETFs Holding This Stock

CUSD logo CUSD CrossingBridge Ultra-Short Duration ETF
1.65% weight
MERFX MERFX
0.70% weight
MERIX MERIX
0.70% weight

All Fundamental Metrics
Growth
Revenue Growth (1Y) N/A Revenue Growth (3Y) N/A
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) N/A Net Income (TTM) 5.45 M
ROE N/A ROA 2.30%
Gross Margin N/A Operating Margin N/A
Net Margin N/A Free Cash Flow (TTM) -586,272.0
ROIC N/A FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio 0.06
Interest Coverage N/A Asset Turnover N/A
Working Capital -428,415 Tangible Book Value -7.33 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio 64.69 Forward P/E N/A
P/B Ratio N/A P/S Ratio N/A
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -0.17%
Market Cap 352.43 M Enterprise Value 352.43 M
Per Share
EPS (Diluted TTM) -0.03 Revenue / Share N/A
FCF / Share -0.02 OCF / Share -0.02
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue N/A FCF Conversion -10.76%
SBC-Adj. FCF N/A Growth Momentum N/A

Income Statement

Annual, most recent first
Metric FY2024
Revenue —
Net Income -279,845.0
EPS (Diluted) -0.03
Gross Profit —
Operating Income —
EBITDA —
R&D Expenses —
SG&A Expenses —
D&A —
Interest Expense —
Income Tax —

Balance Sheet

Annual, most recent first
Metric FY2024
Total Assets 550,824.0
Total Liabilities 795,669.0
Shareholders' Equity -244,845.0
Total Debt —
Cash & Equivalents —
Current Assets 4,991.0
Current Liabilities —